Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumor Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01352273
What this trial is testing

MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations

Who this might be right for
Advanced Solid Tumors
Array Biopharma, now a wholly owned subsidiary of Pfizer 69
Early research (Phase 1)Study completedNCT01497470
What this trial is testing

A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of the Chemotherapeutic Drug, Paclitaxel, When Given Together as Part of a Treatment Regimen

Who this might be right for
Cancer
Achieve Life Sciences 36
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Early research (Phase 1)Ended earlyNCT05166577
What this trial is testing

Nanatinostat Plus Valganciclovir in Advanced EBV+ Solid Tumors and in Combination With Pembrolizumab in EBV+ RM-NPC

Who this might be right for
Nasopharyngeal CarcinomaEBV-Related Gastric CarcinomaEBV-Related Leiomyosarcoma+2 more
Viracta Therapeutics, Inc. 26
Early research (Phase 1)Ended earlyNCT04467853
What this trial is testing

A Clinical Study to Evaluate CAR-T Cell-based Medicinal Product in the Treatment of Advanced Solid Tumors

Who this might be right for
Solid Tumors, Adult
Shanghai East Hospital 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT04999969
What this trial is testing

Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours

Who this might be right for
Locally Advanced or Metastatic Solid Tumours
AstraZeneca 126
Testing effectiveness (Phase 2)Ended earlyNCT03330405
What this trial is testing

Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors

Who this might be right for
Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors
Pfizer 223
Early research (Phase 1)Study completedNCT03735628
What this trial is testing

Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Head and Neck Squamous Cell Carcinoma (HNSCC)Hepatocellular Carcinoma (HCC)
Bayer 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439344
What this trial is testing

Testing Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol Z1A)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 53
Early research (Phase 1)Not Yet RecruitingNCT07593144
What this trial is testing

A Single-Arm, Open-Label Phase Ia/Ib Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of FS-207 in Patients With Advanced Solid Tumors With High Microsatellite Instability (MSI-H)

Who this might be right for
Advanced Solid Tumors
Foresight Therapeutics (Hefei) Co., Ltd. 156
Not applicableStudy completedNCT07167095
What this trial is testing

90-Day Mortality After Emergency Department Discharge in Advanced Cancer

Who this might be right for
Advanced CancerMortalityOncology+2 more
Ankara Etlik City Hospital 1,250
Testing effectiveness (Phase 2)Study completedNCT02869295
What this trial is testing

A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Nektar Therapeutics 28
Early research (Phase 1)Ended earlyNCT05226507
What this trial is testing

Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

Who this might be right for
Advanced Solid TumorOvarian CancerOvarian Clear Cell Carcinoma+5 more
Nuvectis Pharma, Inc. 45
Early research (Phase 1)Ended earlyNCT01529307
What this trial is testing

First in Human Trial of TAS266 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Novartis Pharmaceuticals 6
Testing effectiveness (Phase 2)Study completedNCT02509507
What this trial is testing

Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611

Who this might be right for
Hepatocellular CarcinomaLiver MetastasesCutaneous or Subcutaneous Lymph Node+1 more
Amgen 127
Early research (Phase 1)Study completedNCT01497392
What this trial is testing

Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers

Who this might be right for
Adenocarcinoma of the PancreasStage III Pancreatic CancerStage IV Pancreatic Cancer+1 more
Roswell Park Cancer Institute 26
Testing effectiveness (Phase 2)Ended earlyNCT00130936
What this trial is testing

Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates

Who this might be right for
Gastric CancerEsophageal CancerTumors
AHS Cancer Control Alberta 50
Early research (Phase 1)Study completedNCT00495144
What this trial is testing

A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid Tumors

Who this might be right for
TumorsHypoxia
Threshold Pharmaceuticals 129
Early research (Phase 1)UnknownNCT04941339
What this trial is testing

MRG002 in the Treatment of Patients With HER2-positive Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Shanghai Miracogen Inc. 74
Not applicableUnknownNCT03047811
What this trial is testing

The Study of Targeted NY-ESO-1 T Cell Receptor (TCR) Genetic Modified Autologous T Cells Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Fudan University 15
Next Page